Search
Searching Content by Emmanuelle Poupart from McCarthy Tétrault LLP ordered by Published Date Descending.
Links to Result pages
 
1  
 
Title
Country
Organisation
Author
Date
1
The Quebec Court Of Appeal Renders A Landmark Decision Regarding Prescription Drug Manufacturers' Duty To Warn
In a judgment rendered on May 8, 2019, the Quebec Court of Appeal[1] upheld a Superior Court decision[2] dismissing a class action ...
Canada
28 May 2019
2
Charbonneau Daneau v. Bell Canada, 2015 QCCS 5585
On June 9, 2014, the Court authorized the institution of a class action against Bell Canada and Bell ExpressVu.
Canada
22 Dec 2015
3
First Class Action Involving A Prescription Drug Being Denied Certification In British Columbia?
In Charlton v. Abbott Laboratories, Ltd., 2015 BCCA 26, the Court of Appeal for British Columbia overturned certification of a class action on behalf of all Canadian consumers of sibutramine, a weight-loss drug.
Canada
17 Jul 2015
4
Public Contracts And Bill 26: Recovery Of Amounts Improperly Paid And Changes To The AMF Authorization Regime
The Act applies to all public contracts, not only to contracts in the construction industry, as provided for in former Bill 61 on the same subject, which died on the order paper.
Canada
11 May 2015
5
Landmark Precedent: Court Denies Certification Of A Product Liability Class Action Related To A Drug Withdrawn From The Market
On April 16, 2012, the Honorable Claudine Roy of the Superior Court of Québec refused to authorize the institution of a class action against Abbott Laboratories (Abbott) and Apotex Inc. concerning a weight-loss drug, Meridia® that had been withdrawn by Abbott from the Canadian marketplace, in collaboration with Health Canada.
Canada
25 Apr 2012
Links to Result pages
 
1